Robbert J De Winter Selected Research

Stents

1/2020	Drug-eluting bioresorbable scaffolds in cardiovascular disease, peripheral artery and gastrointestinal fields: a clinical update.
11/2018	Differences in rotational positioning and subsequent distal main branch rewiring of the Tryton stent: An optical coherence tomography and computational study.
1/2018	The STENTYS self-apposing stent technology in coronary artery disease: literature review and future directions.
5/2017	Evaluation of the MiStent sustained sirolimus eluting biodegradable polymer coated stent for the treatment of coronary artery disease: does uniform sustained abluminal drug release result in earlier strut coverage and better safety profile?
1/2017	The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical Coherence Tomography Imaging Analysis.
1/2010	Understanding the role of endothelial progenitor cells in cardiovascular disease, coronary artery lesion progression, and in-stent restenosis.
7/2004	Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robbert J De Winter Research Topics

Disease

7	Myocardial Infarction 02/2023 - 10/2009
6	ST Elevation Myocardial Infarction 02/2011 - 01/2009
5	Thrombosis (Thrombus) 01/2023 - 10/2009
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 10/2011
4	Infarction (Infarctions) 02/2011 - 06/2009
2	Cardiogenic Shock 02/2023 - 01/2009
2	Stroke (Strokes) 01/2023 - 05/2014
2	Atherosclerotic Plaque (Atheroma) 01/2020 - 05/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2010
2	Pathologic Constriction (Stenosis) 11/2018 - 07/2004
2	Acute Coronary Syndrome 01/2017 - 10/2011
1	Ischemic Stroke 01/2023
1	Atherosclerosis 01/2020
1	Hyperplasia 05/2017
1	Coronary Disease (Coronary Heart Disease) 05/2014
1	Heart Failure 10/2011
1	Chest Pain (Chest Pains) 10/2011
1	Unstable Angina 07/2004
1	Septic Shock (Toxic Shock Syndrome) 10/2002
1	Endotoxemia 10/2002
1	Body Weight (Weight, Body) 10/2002

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2010
2	Everolimus FDA Link 01/2020 - 01/2017
2	Sirolimus (Rapamycin)FDA Link 05/2017 - 01/2017
2	Troponin T (Troponin T1)IBA 10/2011 - 04/2010
2	C-Reactive ProteinIBA 10/2011 - 04/2010
2	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2011 - 04/2010
2	CreatinineIBA 04/2010 - 01/2009
1	MicroRNAs (MicroRNA)IBA 01/2020
1	PolymersIBA 05/2017
1	MetalsIBA 05/2017
1	CobaltIBA 01/2017
1	ChromiumIBA 01/2017
1	EnzymesIBA 05/2014
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 05/2014
1	darapladibIBA 05/2014
1	pro-brain natriuretic peptide (1-76)IBA 10/2011
1	Phosphotransferases (Kinase)IBA 04/2010
1	EndotoxinsIBA 10/2002
1	Human Serum Albumin FDA LinkGeneric 10/2002
1	bactericidal permeability increasing proteinIBA 10/2002
1	CytokinesIBA 10/2002

Therapy/Procedure

7	Percutaneous Coronary Intervention 02/2023 - 01/2009
7	Stents 01/2020 - 07/2004
2	Therapeutics 01/2023 - 01/2017
2	Drug-Eluting Stents 05/2017 - 07/2004
1	Thrombectomy 01/2023
1	Patient Readmission 06/2009